Well Lead Medical Co., Ltd. (SHSE:603309) agreed to acquire 31.7% stake in Suzhou Medsure Medical Technology Co., Ltd. from Wang Guangming for CNY 17.7 million on December 11, 2021. For the year ended December 31, 2021 Suzhou Medsure Medical Technology Co., Ltd. recorded the total assets of CNY 15.4 million, EBIT CNY 3 million, Net loss of CNY 11 million and net assets of CNY -4.6 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.23 CNY | +1.33% | +5.25% | -14.05% |
Apr. 19 | Mainland China and Hong Kong stocks fall on Middle East tensions | RE |
Apr. 18 | Well Lead Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.05% | 488M | |
-2.73% | 187B | |
-1.65% | 106B | |
-4.45% | 66.9B | |
+0.69% | 49.45B | |
+16.60% | 48B | |
+4.06% | 40.84B | |
+3.61% | 26.48B | |
+1.26% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 603309 Stock
- News Well Lead Medical Co., Ltd.
- Well Lead Medical Co., Ltd. agreed to acquire 31.7% stake in Suzhou Medsure Medical Technology Co., Ltd. from Wang Guangming for CNY 17.7 million.